How To Avoid China ’ s Medicine Monopoly
I want to share a shocking statistic with you…
Around 80% of all the pharmaceuticals sold in America — both prescription and over-the-counter — are manufactured in China.
I’m talking about drugs for Parkinson’s and Alzheimer’s, blood pressure and blood thinners, diuretics, aspirin, antibiotics, and a big chunk of the world’s insulin and diabetes drugs — just to name a few.1
We don’t even make penicillin anymore. The last penicillin plant in the U.S. closed its doors in 2004.
Americans who rely on medicine are now almost entirely at the mercy of a country whose relations with the U.S. have become more ...
Source: Al Sears, MD Natural Remedies - September 19, 2023 Category: Complementary Medicine Authors: Jacob Tags: Health Source Type: news
Celebrex (celecoxib) Information
celebrex (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 7, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Seglentis (Celecoxib and Tramadol Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 2, 2021 Category: Drugs & Pharmacology Source Type: news
Concensi (Amlodipine and Celecoxib Tablet) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 25, 2021 Category: Drugs & Pharmacology Source Type: news
FDA Approves Combo Pill for Severe, Acute Pain FDA Approves Combo Pill for Severe, Acute Pain
Seglentis contains 56 mg of celecoxib and 44 mg of tramadol and should be reserved for adults with severe refractory pain.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 19, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news
No Benefit Seen From Adjuvant Celecoxib in ERBB2 - Negative Breast Cancer
Disease - free survival did not improve with two years of celecoxib versus placebo in ERBB2 - negative breast cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 16, 2021 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, Journal, Source Type: news
No Benefit Seen From Adjuvant Celecoxib in ERBB2-Negative Breast Cancer
FRIDAY, July 16, 2021 -- For patients with ERBB2-negative breast cancer, two years of treatment with celecoxib as adjuvant to conventional therapy yields no disease-free survival (DFS) benefits compared with placebo, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 16, 2021 Category: Pharmaceuticals Source Type: news
Authorised generic celecoxib good value in Japan
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - July 1, 2021 Category: Drugs & Pharmacology Source Type: news
FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes
[FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes (FDA Drug Safety Communication). Based on FDA ’s comprehensive review of new safety information, the agency is requiring updates to the drug labels of all prescription NSAIDs. Widely used to treat pain and fever from many different long- and short-term medical conditions such as arthritis, menstrual cramps, headaches, colds, and the flu, NSAI Ds are available by prescription and OTC. Examples of NSAIDs include ibuprofen, naproxen, diclofenac, and celecoxib. (Source: FDA Center for Drug Evaluation and...
Source: FDA Center for Drug Evaluation and Research - What's New - June 29, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Consensi (amlodipine and celecoxib)
Title: Consensi (amlodipine and celecoxib)Category: MedicationsCreated: 5/14/2021 12:00:00 AMLast Editorial Review: 5/14/2021 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - May 14, 2021 Category: Cardiology Source Type: news
Unichem Labs gets American drug regulator's nod to market generic Celecoxib capsules
The company has received abbreviated new drug application (ANDA) approval for its Celecoxib capsules in the strengths of 50 mg, 100 mg, 200 mg, and 400 mg from the United States Food and Drug Administration (USFDA), Unichem said in a filing to BSE. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 13, 2021 Category: Pharmaceuticals Source Type: news
FDA Warns of Painkiller Risk During Pregnancy
The FDA warned on Thursday that taking widely used painkillers called NSAIDS -- which include Advil, Motrin, Aleve and Celebrex -- at 20 weeks or later in a pregnancy could raise the risk of complications. (Source: WebMD Health)
Source: WebMD Health - October 16, 2020 Category: Consumer Health News Source Type: news
Gene Therapy Clinical Trial for Mesothelioma Moving Forward
This study will compare the effectiveness of the drug against a control group receiving only the gemcitabine and celecoxib. Patients have a one-in-two chance of being randomly assigned to either the adenovirus treatment or the control group.
Adenovirus-delivered interferon Alpha-2b is designed as a second- or third-line treatment for patients who have failed in earlier regimens. Patients who previously had aggressive mesothelioma surgery but whose tumors have since progressed would be eligible to enroll.
Success at the phase III level would mark the culmination of 20 years of researching and fine tuning gene therapy for us...
Source: Asbestos and Mesothelioma News - September 23, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news
Two anti-inflammatory drugs found that inhibit the replication of the COVID-19 virus
(Universitat Rovira i Virgili) Researchers at the URV have used computer techniques to analyse whether 6,466 drugs authorized by various drug agencies for both human and veterinary use could be used to inhibit the M-pro enzyme. The study demonstrates that a human and a veterinary anti-inflammatory drug - Carprofen and Celecoxib - inhibit a key enzyme in the replication and transcription of the virus responsible for COVID-19. The results of the work have been validated by the initiative COVIDMoonshot. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 27, 2020 Category: Biology Source Type: news
Consensi (Amlodipine and Celecoxib Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 20, 2020 Category: Drugs & Pharmacology Source Type: news
